Current state of and needs for hepatitis B screening: Results of a large screening study in a low-prevalent, metropolitan region

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Bottero, Julie ^a,b,c   Boyd, Anders ^a   Lemoine, Maud ^d   Carrat, Fabrice ^a,b,d   Gozlan, Joel ^d   Collignon, Anne ^e   Boo, Nicolas ^f   Dhotte, Philippe ^g   Varsat, Brigitte ^h   Muller, Gerard ⁱ   Cha, Olivier ^d   Valin, Nadia ^c   Nau, Jean ^j   Campa, Pauline ^c   Silbermann, Benjamin ^k   Bary, Marc ^l   Girard, Pierre Marie ^a,b,c   Lacombe, Karine ^a,b,c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e Laboratoire St Marcel Mairie de Paris   (France)

^f Mairie de Paris   (France)

^g Centre de de Pistage Anonyme et Gratuit (CDAG) du Figuier Mairie de Paris   (France)

^h CPAM de Paris   (France)

ⁱ CDAG de Belleville   (France)

^j République Démocratique du Congo   (France)

^k Unité de Consultation et de Soins Ambulatoires UCSA Maison d'Arrêt de la Santé   (France)

^l Centre Croix Rouge du Moulin Joly   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; GEOGRAPHIC ORIGIN; HEALTH CARE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PUBLIC HEALTH SERVICE; QUESTIONNAIRE; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; BLOOD; CITY; EPIDEMIOLOGY; HEALTH SERVICE; MASS SCREENING; MIDDLE AGED; PHYSICIAN; PREVALENCE; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CITIES; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PHYSICIANS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; UNITED STATES;

EID: 84899718859     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092266     Document Type: Article

References (26)

1. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, et al. (2005) A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34: 1329-1339. (Pubitemid 41819540)
2. WHO (2012) Hepatitis B: World Health Organization Fact Sheet 204. 2012. http://wwwwhoint/mediacentre/factsheets/fs204/en/.
3. Hatzakis A, Wait S, Bruix J, Buti M, Carballo M, et al. (2011) The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat 18 Suppl 1: 1-16.
4. ELPA (2010) Report on hepatitis patient self-help in Europe. European Liver Patients. Association: http://wwwhepbcppaorg/wp-content/uploads/2011/11/ Report-on-Patient-Self-Helppdf.
5. IOM (2010) Institute of Medicine. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. The National Academies Press.
6. Meffre C, Le Strat Y, Delarocque-Astagneau E, Antona D, Desenclos JC (2006) Prévalence des hépatites B et C en France en 2004. http://www.invs.sante.fr/publications/2006/prevalence-b-c/index.htm.
7. Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, et al. (2008) Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 57: 1-20.
8. Crutzen R, Goritz AS (2012) Public awareness and practical knowledge regarding Hepatitis A, B, and C: a two-country survey. J Infect Public Health 5: 195-198.
9. Xiong M, Nguyen RH, Strayer L, Chanthanouvong S, Yuan JM (2013) Knowledge and Behaviors Toward Hepatitis B and the Hepatitis B Vaccine in the Laotian Community in Minnesota. J Immigr Minor Health.
10. Tosini S, Rioux C, Pelissier G, Bouvet E (2009) Étude de perception des risques de l'hépatite virale B et de sa prévention vaccinale dans une Consultation de dépistage anonyme et gratuit (CDAG) parisienne en 2007. Bull Epidemiol Hebd 2009 20-21: 217-220.
11. Coates TJ, Richter L, Caceres C (2008) Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet 372: 669-684.
12. DGS (2009) Plan national de lutte contre les hépatites B et C (2009-2012). http://wwwsante-sportsgouvfr/IMG/pdf/Plan-hepatites-2009-2012pdf.
13. Spenatto N, Boulinguez S, Mularczyk M, Molinier L, Bureau C, et al. (2013) Hepatitis B screening: Who to target? A French sexually transmitted infection clinic experience. J Hepatol 58: 690-697.
14. Hu DJ, Xing J, Tohme RA, Liao Y, Pollack H, et al. (2013) Hepatitis B testing and access to care among racial and ethnic minorities in selected communities across the United States, 2009-2010. Hepatology.
15. Perumalswami PV, Factor SH, Kapelusznik L, Friedman SL, Pan CQ, et al. (2013) Hepatitis Outreach Network: A practical strategy for hepatitis screening with linkage to care in foreign-born communities. J Hepatol 58: 890-897.
16. Wong WW, Woo G, Jenny Heathcote E, Krahn M (2011) Cost effectiveness of screening immigrants for hepatitis B. Liver Int 31: 1179-1190.
17. WHO (2002) Hepatitis B. http://wwwwhoint/csr/disease/hepatitis/ HepatitisB-whocdscsrlyo2002-2pdf.
18. Bottero J, Boyd A, Gozlan J, Lemoine M, Carrat F, et al. (2013) Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France. J Hepatol 58: 473-478.
19. EASL (2012) EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 57: 167-185.
20. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
21. IGF (2010) Inspection Générale des Finances. Analyse de l'évolution des dépenses au titre de l'aide médicale d'État, rapport officiel http://wwwladocumentationfrancaisefr/var/ storage/rapports-publics/104000685/0000pdf.
22. Insee (2009) Recensement 2009, exploitation principale. http://wwwinseefr/fr/themes/tableauasp?reg-id=20&ref-id=poptc02501.
23. ECDC (2010) European Centre for Disease Prevention and Control (ECDC). Surveillance and prevention of hepatitis B and C in Europe. ECDC technical report, Stockholm, October 2010. http://ecdceuropaeu/en/publications/ Publications/101012-TER-HepBandC-surveypdf.
24. Insee (2010) Évolution de l'âge moyen et de l'âgemédian de la population jusqu'en 2014. http://wwwinseefr/fr/ themes/tableauasp?ref-id=NATnon02147.
25. d'Almeida KW, Kierzek G, de Truchis P, Le Vu S, Pateron D, et al. (2012) Modest public health impact of nontargeted human immunodeficiency virus screening in 29 emergency departments. Arch Intern Med 172: 12-20.
26. Scott C, Day S, Low E, Sullivan A, Atkins M, et al. (2010) Unselected hepatitis C screening of men who have sex with men attending sexual health clinics. J Infect 60: 351-353.